A preliminary FDA review questioned whether Sanofi’s diabetes drug lixisenatide contributed any benefit to a fixed-dose combo product the company hopes to market.
Portuguese drugmaker Bial and French laboratory Biotrial are at fault “on several counts” for a fatal drug trial that left one person dead and five others hospitalized in January, French Health Minister Marisol Touraine said.
Sanofi has shuffled around some of its top leaders in support of its 2020 strategic roadmap as three executives have announced their intentions leave the company.
Atlanta-based Arbor Pharmaceuticals announced that it was acquiring Santa Clara, California-based XenoPort for approximately $467 million.
Australia’s competition watchdog has filed an appeal against a fine of A$1.7 million ($1.2 million) imposed on British consumer goods giant Reckitt Benckiser for misleading consumers on painkiller marketing, arguing that it is too light.
Join the GTO Group for a free webinar exploring how marketing, media, design, and technology are converging in order to effectively reach and empower patients, caregivers, and HCPs.
The World Bank said it was launching a $500 million, fast-disbursing insurance fund to combat deadly pandemics in poor countries, creating the world’s first insurance market for pandemic risk.
The U.S. FDA said it would update guidelines for nutritional labels on packaged food and beverages to include info on added sugar and to prominently display calorie count and servings.
Some 157 pregnant women in the United States and another 122 in U.S. territories have tested positive for infection with the Zika virus, the U.S. Centers for Disease Control and Prevention said.
A late-stage trial will begin later this year in South Africa to test the effectiveness of an HIV vaccine that has shown promise in earlier trials, according to the National Institutes of Health.